These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35116491)

  • 1. Significance of risk factor analysis and dissection for station 4L lymphatic metastasis in left lung cancer: a systematic review and meta-analysis.
    Wang CX; Xu C; Li C; Ding C; Chen J; Zhao J
    Transl Cancer Res; 2021 Apr; 10(4):1656-1666. PubMed ID: 35116491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of 4L Lymph Node Dissection in Left Lung Cancer.
    Wang YN; Yao S; Wang CL; Li MS; Sun LN; Yan QN; Tang SW; Zhang ZF
    J Clin Oncol; 2018 Oct; 36(29):2935-2942. PubMed ID: 30148659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of 4L lymph node for left-sided non-small cell lung cancer: a meta-analysis.
    Deng HY; Li D; Qiu XM; Zhu DX; Tang X; Zhou Q
    ANZ J Surg; 2021 Nov; 91(11):E696-E702. PubMed ID: 34405519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and survival impact of station 4L metastasis in left non-small cell lung cancer.
    Fang L; Wang L; Wang Y; Wu Y; Ye P; Lv W; Hu J
    J Cancer Res Clin Oncol; 2019 May; 145(5):1313-1319. PubMed ID: 30877377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological characteristics and risk factors of station 4L lymph node metastasis of left non-small cell lung cancer].
    Shen L; Yun T; Guo J; Liu Y; Liang C
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1793-1798. PubMed ID: 33380404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and survival outcomes of 4L lymph node dissection in left lung adenocarcinoma and squamous cell carcinoma.
    Shen L; Guo J; Zhang W; Liang C; Chen H; Liu Y
    Front Oncol; 2023; 13():1124014. PubMed ID: 37114135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediastinal lymph node evaluation, especially at station 4L, in left upper lobe lung cancer.
    Hanaoka J; Yoden M; Okamoto K; Kaku R; Ohshio Y
    J Thorac Dis; 2022 Sep; 14(9):3321-3334. PubMed ID: 36245624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of 4L lymph node dissection in left-side operable non-small-cell lung cancer: a meta-analysis.
    Peng L; Huang KL; Shang QW; Wang Y; Li W
    Updates Surg; 2024 Jan; 76(1):23-32. PubMed ID: 37938527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Benefit of Left Lower Paratracheal (4L) Lymph Node Dissection for Patients with Left-Sided Non-small Cell Lung Cancer: Once Neglected But of Great Importance.
    Zhao K; Wei S; Mei J; Guo C; Hai Y; Chen N; Liu L
    Ann Surg Oncol; 2019 Jul; 26(7):2044-2052. PubMed ID: 31011902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer.
    Zhou D; Yue D; Zhang Z; Tian P; Feng Y; Liu Z; Zhang B; Wang M; Zhao X; Wang C
    World J Surg Oncol; 2022 Jul; 20(1):222. PubMed ID: 35778770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of left lower paratracheal (4L) lymph node dissection on survival in patients with surgically treated left-sided NSCLC.
    Gryszko GM; Cackowski MM; Zbytniewski M; Woźnica K; Orłowski TM; Dziedzic DA;
    Eur J Cardiothorac Surg; 2021 Nov; 60(5):1201-1209. PubMed ID: 34279610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.
    Liu C; Wei S; Guo C; Mei J; Pu Q; Liu L
    Ann Surg Oncol; 2021 Jan; 28(1):194-202. PubMed ID: 32638165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thirty years' changes of the strategy of lateral lymph node dissection in low rectal cancer: treatment experience and prognostic analysis of 289 cases in one single center].
    Tang JQ; Li HY; Liu T; Zhang JL; Zuo S; Sun L; Wu YC; Jiang Y; Chen GW; Wu T; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):889-896. PubMed ID: 34674464
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.
    Yang MZ; Hou X; Li JB; Cai JS; Yang J; Li S; Long H; Fu JH; Zhang LJ; Lin P; Rong TH; Yang HX
    Eur J Cardiothorac Surg; 2020 Jun; 57(6):1181-1188. PubMed ID: 32016340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis.
    Kuroda H; Sakao Y; Mun M; Uehara H; Nakao M; Matsuura Y; Mizuno T; Sakakura N; Motoi N; Ishikawa Y; Yatabe Y; Nakagawa K; Okumura S
    PLoS One; 2015; 10(8):e0134674. PubMed ID: 26247881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.
    Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M
    Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postoperative survival analysis of patients with stage Ⅲ-pN2 non-small cell lung cancer].
    Wu XW; Chen T; Yin S; Deng Y; Zhao B
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):782-786. PubMed ID: 30392344
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of extranodal extension in sentinel lymph node positive breast cancer.
    Yang X; Ma X; Yang W; Shui R
    Sci Rep; 2020 Sep; 10(1):14684. PubMed ID: 32895434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.